Wednesday, July 18, 2018
 
 
Company News: Page (1) of 1 - 07/10/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
SCPC to Work with Senate to Advance Provision Recognizing Unique Status, Medication Needs of Hospice, Long Term Care (LTC) Patients
Praises U.S. House Support of HR 6, Effort by Rep. Roskam to Assist LTC and Hospice Patients
(July 10, 2018)

WASHINGTON, July 10, 2018 /PRNewswire-USNewswire/ --In praising passage of HR 6, which includes dozens of bills to fight the nationwide epidemic of opioid abuse, the Senior Care Pharmacy Coalition (SCPC) today said it looks forward to working with the U.S. Senate and Senators Pat Toomey (R-PA) and Claire McCaskill (D-MO) to advance a key long-term care (LTC) pharmacy provision recognizing the unique needs and medication challenges facing LTC patients.

"SCPC thanks the U.S. House for passing an array of bills to address the nation's opioid abuse crisis late last month," stated Alan G. Rosenbloom, President and CEO of SCPC, the only federal advocacy organization devoted exclusively to the interests of the nation's LTC pharmacies and the patients they serve. "We commend lawmakers and bipartisan House leadership for recognizing the LTC patient population is distinct from the general population. LTC pharmacies have far more intensive medication management and ongoing clinical responsibilities for these patients, and several key provisions in the package have been modified to address these needs."

One bill in the House package, sponsored by Rep. Peter Roskam (R-IL), exempts patients in hospice programs from a technical requirement, but the House did not have time to add such an exemption for LTC patients. Rosenbloom noted, however, that neither Mr. Roskam nor others in the House have any concerns about the proposed modification. "SCPC thanks the entire House for recognizing the unique requirements of seniors residing in hospice and LTC settings -- and how they require different treatment compared to other patients. We remain confident that the one remaining area of concern will be addressed before the Senate finalizes a unified opioid crisis response package."



In the overall debate on opioid availability, Rosenbloom noted sensible limits on prescription access should be enacted as soon as possible. "Patients in LTC settings, like those in hospice care, are at extremely low risk for opioid abuse," he observed. "Compared to the general population, the LTC patient population has a much greater prevalence of multiple chronic conditions, suffers severe chronic pain and breakthrough pain more often, takes significantly more prescription medications each day, faces a higher incidence of adverse drug reactions to opioid alternatives, and a higher prevalence of complications from polypharmacy," Rosenbloom stated.

Rosenbloom noted that Senators Toomey and McCaskill have co-sponsored a bill similar to Rep. Roskam's bill, and said SCPC appreciates the fact Senators Toomey and McCaskill understand the need to treat LTC patients appropriately. Sen. Toomey, he noted, led Senate efforts to treat Medicare Part D beneficiaries differently in passage of the Comprehensive Addiction and Recovery Act (CARA 1.0) of 2016. "We are confident Senators Toomey and McCaskill will do all they can to assure that distinct treatment of LTC pharmacies remains consistent with that precedent as the Senate advances a comprehensive legislative response this year," the SCPC leader continued.

Rosenbloom pointed out that LTC pharmacies maintain stringent oversight of patients' entire drug regimens. "The methods of specialized and patient-specific packaging, delivery, dispensing, and tracking medications combined with ongoing clinical responsibilities results in LTC pharmacies satisfying extraordinarily high safety and compliance standards," he continued.

"With the Senate now working to pass its own bill, we look forward to collaborating with the HELP and Finance Committees -- and key lawmakers like Senators Toomey and McCaskill -- to assure that LTC patients receive the appropriate pain management protocols," Rosenbloom concluded. "We hope both chambers can proceed expeditiously to pass legislation to address this urgent public health issue."

The Senior Care Pharmacy Coalition (SCPC) is the only national organization exclusively representing the interests of LTC pharmacies. Its members operate in all 50 states and serve 750,000 patients daily in skilled nursing and assisted living facilities across the country. Visit seniorcarepharmacies.orgto learn more.

Cision View original content:http://www.prnewswire.com/news-releases/scpc-to-work-with-senate-to-advance-provision-recognizing-unique-status-medication-needs-of-hospice-long-term-care-ltc-patients-300678737.html

SOURCE Senior Care Pharmacy Coalition

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:USA,Medicine,Insurance,Cancer,Surgery,Medication,Seniors Health,Seniors,Insurance Companies,Science,Medical,Other,
Related Sites: DMN Newswire ,   itbusinessnet.com ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   IBN - IT Weekly Newsletter ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Implantable Medical Devices Market Predicted to be Worth US$ 49.8 Bn by 2024, Says TMR
  • Global Cosmetic Chemicals Industry
  • HMP's 8th Annual Amputation Prevention Symposium Expected to Draw 800 Clinicians to Chicago to Join the CLI Revolution
  • Progressive Care Inc. Announces Month-End Sales Figures Showing Increase in Year-Over-Year Prescriptions Filled in June 2018

    Cancer
  • Camurus Announces PDUFA Date for CAM2038 for the Treatment of Opioid use Disorder
  • Small Animal Imaging Market is Estimated to Grow at a Faster Pace With the Significant CAGR During the Forecast Period: Radiant Insights, Inc.
  • Presage Biosciences Closes Series D Financing with Takeda and Celgene, and Announces Appointment of Richard Klinghoffer, PhD as Chief Executive Officer
  • Presage Biosciences Closes Series D Financing with Takeda and Celgene, and Announces Appointment of Richard Klinghoffer, PhD as Chief Executive Officer
  • Corporate Whistleblower Center Now Targets Hospice Providers Ripping Off Medicare And Urges Their Employees with Proof a of Wrongdoing to Call About Rewards -- Don't Get Mad, Get Even
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines